Vascular function measurements in the presence of cyclooxygenase (COX) inhibitor and the immunohistochemical labeling of endothelial nitric oxide synthase (eNOS) in these vessels suggest that eNOS and prostanoid pathways may play a role in the gender-specific vascular dysfunction in vitamin D deficiency [17]. The gene discussed is NOS3; the disease is vitamin D deficiency.